Promising cell therapy trial for tough lymphoma pulled before it started
NCT ID NCT06313996
First seen Mar 21, 2026 · Last updated May 01, 2026 · Updated 6 times
Summary
This study was designed to compare a new cell therapy called Liso-cel against standard treatments for adults with follicular lymphoma that has come back or stopped responding to prior therapy. The goal was to see if Liso-cel could better control the disease and improve survival. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.